Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors

被引：0
|
作者：
Paola Mapelli
Carolina Bezzi
Francesca Muffatti
Samuele Ghezzo
Francesco Baldassi
Marco Schiavo Lena
Valentina Andreasi
Carla Canevari
Patrizia Magnani
Francesco De Cobelli
Luigi Gianolli
Stefano Partelli
Massimo Falconi
Maria Picchio
机构：
[1] Vita-Salute San Raffaele University,Nuclear Medicine Department
[2] IRCCS San Raffaele Scientific Institute,Pancreatic Surgery Unit
[3] IRCCS San Raffaele Scientific Institute,Pathology Unit
[4] University of Milano-Bicocca,Department of Radiology
[5] IRCCS San Raffaele Scientific Institute,undefined
[6] IRCCS San Raffaele Scientific Institute,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Ga-DOTA-peptides; Pancreatic neuroendocrine tumor; PET; Predictive value; DAXX; ATRX; Risk assessment; Preoperative; Somatostatin receptor activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2818 / 2829
页数：11
相关论文
共 50 条
  • [31] Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)
    Vega-Zolano, Elizabeth
    Ruiz, Erika
    Caderillo-Ruiz, German
    Diaz, Consuelo
    Herrera, Marytere
    Torres Agredo, Liliana Patricia
    Soldevilla-Gallardo, Irma
    Michel-Sanchez, Emiliano
    Garcia-Perez, Francisco Osvaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Role of Combined 68Ga-DOTATOC and 18F-FDG PET-CT in the Diagnostic Workup of Well Differentiated Pancreas Neuroendocrine Tumors (PanNETs): A Surgical Series
    Ortolani, S.
    Butturini, G.
    Malpaga, A.
    Cingarlini, S.
    Malfatti, V
    Capelli, P.
    Ruzzenente, A.
    Regi, P.
    Vallerio, P.
    Grego, E.
    Tortora, G.
    Scarpa, A.
    Bassi, C.
    Salgarello, M.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 113 - 113
  • [33] Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
    Muessig, K.
    Oeksuez, M.
    Dudziak, K.
    Ueberberg, B.
    Wehrmann, M.
    Horger, M.
    Schulz, S.
    Pfannenberg, C.
    Gallwitz, B.
    Petersenn, S.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 47 - 47
  • [34] Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
    Muessig, K.
    Oeksuez, M. Oe.
    Dudziak, K.
    Ueberberg, B.
    Wehrmann, M.
    Horger, M.
    Schulz, S.
    Haering, H. U.
    Pfannenberg, C.
    Bares, R.
    Gallwitz, B.
    Petersenn, S.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (08) : 599 - 606
  • [35] Dynamic Ga-68 DOTATOC PET for segregation of tumor perfusion from somatostatin receptor expression on neuroendocrine tumor (NET)
    Steffen, Ingo
    Hofheinz, Frank
    Pavel, Marianne
    Brenner, Winfried
    Prasad, Vikas
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [36] Can Texture Analysis Be Used for a Vivo "Imaging Biopsy" in Neuroendocrine Tumors? A First Step Feasibility Study with 68Ga-DOTATOC PET/CT
    Liberini, V
    De Santi, B.
    Gallio, E.
    Pilati, E.
    Finessi, M.
    Bello, M.
    Papotti, M.
    Maletta, F.
    Volante, M.
    Bisi, G.
    Molinari, F.
    Deandreis, D.
    NEUROENDOCRINOLOGY, 2019, 108 : 218 - 218
  • [37] Correlation study between 68Ga-DOTATOC PET/CT metrics and 177Lu-DOTATATE dosimetry for non-pancreatic neuroendocrine tumors
    Texier, J. S.
    Jocmek, M.
    Dierickx, L.
    Vallot, D.
    Brillouet, S.
    Lamesa, C.
    Courbon, F.
    Vija, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 160 - 160
  • [38] Gastroenteropancreatic Neuroendocrine Tumor Patients Imaged Favorably With Somatostatin Receptor Antagonist: Results of a Phase I/II Study Comparing 68Ga-OPS202 With 68Ga-DOTATOC PET/CT
    Nicolas, Guillaume P.
    Kaul, Felix
    Mena, Ramon
    Bouterfa, Hakim
    Lassmann, Michael
    Schreiter, Nils
    Fani, Melpomeni
    Wild, Damian
    PANCREAS, 2016, 45 (03) : 479 - 479
  • [39] Prognostic value of volumetric parameters calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
    Toriihara, Akira
    Baratto, Lucia
    Nobashi, Tomomi
    Park, Sonya
    Hatami, Negin
    Davidzon, Guido
    Kunz, Pamela
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [40] The role of quantitative tumor burden based on [68 Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis
    Luohai Chen
    Nuerailaguli Jumai
    Qiao He
    Man Liu
    Yuan Lin
    Yanji Luo
    Yu Wang
    Min-hu Chen
    Zhirong Zeng
    Xiangsong Zhang
    Ning Zhang
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 525 - 534
12345